Icatibant

Create: 01/15/2017

Expired Date:	never
Category:	Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:	Icatibant (Firazyr) is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play a significant role. https://www.creative-peptides.com/product/icatibant-item-10-101-163-33649.html






City:	Shirley[US]
Location:

Aug 09 2019	HLA-A_24_02 CMV pp65 tetramer-QYDPVAALF-PE labeled	449
Aug 09 2019	H-2Db LCMV gp33 tetramer-KAVYNFATC-APC labeled	463
Aug 09 2019	H-2Kb TRP-2 tetramer-SVYDFFVWL-PE labeled	438
Aug 09 2019	H-2Db WT1 tetramer-RMFPNAPYL-PE labeled	361
Aug 09 2019	H-2Kb HBV core tetramer-MGLKFRQL-APC labeled	443
Aug 09 2019	T-Select H-2Kb Negative (SIY) tetramer-SIYRYYGL-PE labeled	419
Aug 09 2019	T-Select H-2Kb MuLV p15E tetramer-KSPWFTTL-PE labeled	447
Aug 09 2019	T-Select H-2Kb OVA tetramer-SIINFEKL-APC labeled	477
Aug 09 2019	T-Select HLA-A_24_02 survivin-2B tetramer-AYACNTSTL-APC labeled	416
Aug 09 2019	T-Select HLA-A_02_01 CMV pp65 tetramer-NLVPMVATV-PE labeled	446